These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 23408560)

  • 1. Statistical visualization for assessing performance of methods for safety surveillance using electronic databases.
    Li X; Hui S; Ryan P; Rosenman M; Overhage M
    Pharmacoepidemiol Drug Saf; 2013 May; 22(5):503-9. PubMed ID: 23408560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug safety data mining with a tree-based scan statistic.
    Kulldorff M; Dashevsky I; Avery TR; Chan AK; Davis RL; Graham D; Platt R; Andrade SE; Boudreau D; Gunter MJ; Herrinton LJ; Pawloski PA; Raebel MA; Roblin D; Brown JS
    Pharmacoepidemiol Drug Saf; 2013 May; 22(5):517-23. PubMed ID: 23512870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Empirical assessment of methods for risk identification in healthcare data: results from the experiments of the Observational Medical Outcomes Partnership.
    Ryan PB; Madigan D; Stang PE; Overhage JM; Racoosin JA; Hartzema AG
    Stat Med; 2012 Dec; 31(30):4401-15. PubMed ID: 23015364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Challenges in the design and analysis of sequentially monitored postmarket safety surveillance evaluations using electronic observational health care data.
    Nelson JC; Cook AJ; Yu O; Dominguez C; Zhao S; Greene SK; Fireman BH; Jacobsen SJ; Weintraub ES; Jackson LA
    Pharmacoepidemiol Drug Saf; 2012 Jan; 21 Suppl 1():62-71. PubMed ID: 22262594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of databases in drug postmarketing surveillance.
    Rodriguez EM; Staffa JA; Graham DJ
    Pharmacoepidemiol Drug Saf; 2001; 10(5):407-10. PubMed ID: 11802586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An evaluation of the THIN database in the OMOP Common Data Model for active drug safety surveillance.
    Zhou X; Murugesan S; Bhullar H; Liu Q; Cai B; Wentworth C; Bate A
    Drug Saf; 2013 Feb; 36(2):119-34. PubMed ID: 23329543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel algorithm for detection of adverse drug reaction signals using a hospital electronic medical record database.
    Park MY; Yoon D; Lee K; Kang SY; Park I; Lee SH; Kim W; Kam HJ; Lee YH; Kim JH; Park RW
    Pharmacoepidemiol Drug Saf; 2011 Jun; 20(6):598-607. PubMed ID: 21472818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minimizing signal detection time in postmarket sequential analysis: balancing positive predictive value and sensitivity.
    Maro JC; Brown JS; Dal Pan GJ; Kulldorff M
    Pharmacoepidemiol Drug Saf; 2014 Aug; 23(8):839-48. PubMed ID: 24700557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combining multiple healthcare databases for postmarketing drug and vaccine safety surveillance: why and how?
    Trifirò G; Coloma PM; Rijnbeek PR; Romio S; Mosseveld B; Weibel D; Bonhoeffer J; Schuemie M; van der Lei J; Sturkenboom M
    J Intern Med; 2014 Jun; 275(6):551-61. PubMed ID: 24635221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing the extent and impact of the masking effect of disproportionality analyses on two spontaneous reporting systems databases.
    Maignen F; Hauben M; Hung E; Van Holle L; Dogne JM
    Pharmacoepidemiol Drug Saf; 2014 Feb; 23(2):195-207. PubMed ID: 24243665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Research on drug safety and effectiveness using pharmacoepidemiological databases.
    Andersen M
    J Intern Med; 2014 Jun; 275(6):548-50. PubMed ID: 24635741
    [No Abstract]   [Full Text] [Related]  

  • 12. Hepatitis B vaccination and multiple sclerosis: a data mining perspective.
    Hauben M; Sakaguchi M; Patadia V; M Gerrits C
    Pharmacoepidemiol Drug Saf; 2007 Aug; 16(8):943-5. PubMed ID: 17636551
    [No Abstract]   [Full Text] [Related]  

  • 13. Active drug safety surveillance: a tool to improve public health.
    Platt R; Madre L; Reynolds R; Tilson H
    Pharmacoepidemiol Drug Saf; 2008 Dec; 17(12):1175-82. PubMed ID: 18823068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pediatric post-marketing safety systems in North America: assessment of the current status.
    McMahon AW; Wharton GT; Bonnel R; DeCelle M; Swank K; Testoni D; Cope JU; Smith PB; Wu E; Murphy MD
    Pharmacoepidemiol Drug Saf; 2015 Aug; 24(8):785-92. PubMed ID: 26098297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are all quantitative postmarketing signal detection methods equal? Performance characteristics of logistic regression and Multi-item Gamma Poisson Shrinker.
    Berlin C; Blanch C; Lewis DJ; Maladorno DD; Michel C; Petrin M; Sarp S; Close P
    Pharmacoepidemiol Drug Saf; 2012 Jun; 21(6):622-30. PubMed ID: 21994119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Causal association in pharmacovigilance and pharmacoepidemiology: thoughts on the application of the Austin Bradford-Hill criteria.
    Shakir SA; Layton D
    Drug Saf; 2002; 25(6):467-71. PubMed ID: 12071785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Signal detection using change point analysis in postmarket surveillance.
    Xu Z; Kass-Hout T; Anderson-Smits C; Gray G
    Pharmacoepidemiol Drug Saf; 2015 Jun; 24(6):663-8. PubMed ID: 25903221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An evaluation of computer-aided disproportionality analysis for post-marketing signal detection.
    Lehman HP; Chen J; Gould AL; Kassekert R; Beninger PR; Carney R; Goldberg M; Goss MA; Kidos K; Sharrar RG; Shields K; Sweet A; Wiholm BE; Honig PK
    Clin Pharmacol Ther; 2007 Aug; 82(2):173-80. PubMed ID: 17507922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generating signals of drug-adverse effects from prescription databases and application to the risk of arrhythmia associated with antibacterials.
    Corrao G; Botteri E; Bagnardi V; Zambon A; Carobbio A; Falcone C; Leoni O
    Pharmacoepidemiol Drug Saf; 2005 Jan; 14(1):31-40. PubMed ID: 15390219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Empirical assessment of case-based methods for drug safety alert identification in the French National Healthcare System database (SNDS): Methodology of the ALCAPONE project.
    Thurin NH; Lassalle R; Schuemie M; Pénichon M; Gagne JJ; Rassen JA; Benichou J; Weill A; Blin P; Moore N; Droz-Perroteau C
    Pharmacoepidemiol Drug Saf; 2020 Sep; 29(9):993-1000. PubMed ID: 32133717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.